Urge your members of Congress to support continued medical research funding
The bipartisan Medicare Access and CHIP Reauthorization Act (MACRA), signed into law April 2015, eliminated the Sustainable Growth Rate (SGR) and replaced it with the Quality Payment Program (QPP). Clinicians billing Medicare Part B, who meet the eligibility requirements, must participate in the QPP through one of two tracks: the Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMS). The information below provides an overview of MACRA and its impact on hematology.
Disclaimer: The information provided here is intended as a general overview and is not comprehensive.
ASH's comments on the Centers for Medicare and Medicaid Services' final rule on the new payment system.
ASH's comments on the regulations proposed by the Centers for Medicare and Medicaid Services on May 9, 2016.
This webinar provides an overview of the final rule and its impact on hematology.
Questions and answers on MACRA
ASH's letter to CMS on episode-based cost measure development for the Quality Payment Program.
If you have additional questions related to MACRA, please contact Leslie Brady, Policy and Practice Manager, at lbrady@hematology.org or 202-292-0264.
Blood: How I Treat Hematology 2016 ASH Academy ASH On Demand
September 8 - 9, 2017 Chicago, IL
Hear the top experts in hematologic malignancies discuss the latest developments in clinical care and find answers to your most challenging patient care questions.
Instantly access webcasts from ASH's many educational meetings and webinars.